HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure (Q40194102)

18 September 2017

title

HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure (English)

1 reference

18 September 2017

Mei-Liang Huang

1 reference

18 September 2017

Wen-Ling Liao

series ordinal

1 reference

18 September 2017

Mei-Shang Ho

series ordinal

1 reference

18 September 2017

language of work or name

English

0 references

publication date

29 June 2007

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

page(s)

6326-6333

1 reference

Vertical Transmission of Hepatitis B Antigen in Taiwan

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Hepatitis viruses in southern taiwan—mass survey of 2985 inhabitants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Ethnic differences in immune responses to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Patterns of circulating hepatitis B surface antigen variants among vaccinated children born to hepatitis B surface antigen carrier and non-carrier mothers. A population-based comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Combined active-passive immunization against the hepatitis B virus: five-year follow-up of children born to hepatitis B surface antigen-positive mothers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Hepatitis B vaccination in children: persistence of immunity at 9 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.06.022

1 reference

18 September 2017

1 reference